{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-396644","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2026-09-21T20:01:07+00:00","discovered_at":"2026-09-21T20:02:03.844822+00:00","generated_at":"2026-09-21T20:02:08.717002+00:00","sec_items":["1.03","2.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sangamo sells Fabry gene therapy ST-920 to PTC for $111M cash; Nasdaq delisting Sept 27","bullets":["Completed Sept 17, 2026 sale of ST-920 (isaralgagene civaparvovec) to PTC Therapeutics for $111M cash at close.","Up to $100M in additional milestone-based contingent consideration; PTC assumes specified liabilities.","Court approved sale Sept 2, 2026 (Docket No. 426) following Aug 10 auction where PTC was successful bidder.","Nasdaq delisting effective Sept 27, 2026 after Form 25 filed Sept 17; stock trades OTC under SGMOQ.","Company operates as debtor-in-possession in Chapter 11 Case No. 26-10989 (Delaware Bankruptcy Court)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-396644","json":"https://secwatch.observer/filing/0001193125-26-396644.json","markdown":"https://secwatch.observer/filing/0001193125-26-396644.md","text":"https://secwatch.observer/filing/0001193125-26-396644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526396644/0001193125-26-396644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526396644/d178611d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-21T20:02:08.717002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}